Art is Her Best Friend

Yvonne is living her dream. She is an artist, dedicated to raising awareness and funds for vision research.

Meet Molly Burke, FFB Youth Ambassador

Youth Ambassador

Molly Burke is a youth ambassador for the FFB, educating the public about living with blindness while delivering a message of hope to those living with vision impairment.

Meet Norma Bastidas, mom on a mission

Mom on a Mission

Norma is the second person in history to run 7 of the planet's most unforgiving environments on 7 continents in 1 year in support of vision research. Read her about incredible journey.

Meet Dale Turner, proof that research does work

Miracles do happen

Dale Turner is the first Canadian to receive an experimental treatment and have some sight restored by gene therapy. Dale is proof that investing in research works.

Check out our FFB Facebook group


  • Monthly Giving Program

    An easy way to fund vision research

  • Join the Fight for Sight

    Become a Sight Saver today and show your commitment to sight saving research

  • Vision Quest 2011 - Audio/Video Now Available

    Vision Quest 2011 - From Coast to Coast Halifax | Toronto | Vancouver.

  • Ride for Sight

    Canada's longest running motorcycle fundraiser and weekend celebration

News & Events

  • Comic Vision Tickets On Sale

    Comic Vision tickets go on sale today. The stand up comedy tour will be in London (April 24), Oakville (April 25), Toronto (April 26), Vancouver (May 2) and Calgary (May 3). Get your tickets now at the Comic Vision website.

    link to Comic Vision website

  • Wide-Spread Media Reports on Stem Cell Trials for AMD and Stargardt Disease

    Jan 24, 2012 - Very preliminary results are being reported today from two clinical trials of an embryonic stem cell treatment for Stargardt disease and age-related macular degeneration (AMD).

    continue reading "Stem Cell Trials for AMD and Stargardt Disease"

  • Nanoparticles may prove useful for treating retinal degenerative diseases

    Jan 23, 2012 - A new treatment using tiny nanoparticles to carry drug into the cells of the retina may one day help protect the vision of people with retinitis pigmentosa (RP) and age-related macular degeneration (AMD).

    continue reading "Nanoparticles may prove useful..."

  • Another Group of Stem Cells Discovered in the Human Eye

    Jan 16, 2011 - A team of New York-based scientists has discovered another type of stem cell in the adult human eye. Both this discovery, and an earlier discovery by Dr. Derek van der Kooy of a different stem cell population, may ultimately be useful tools to develop sight-saving treatments.

    continue reading "Another Group of Stem Cells Discovered..."

  • Electronic Devices to Mimic Sight Making Strides

    Dec 18, 2011 - Scientific American is one of the best known science magazines for the general public. This month, the esteemed magazine published an article describing the technologies available to simulate sight for people with retinitis pigmentosa and other blinding diseases.

    continue reading "Electronic Devices to Mimic Sight..."

  • Ten Research Discoveries in 2011

    Dec 14, 2011 - Canadian researchers continue to move us closer to treatments for retinal degenerative diseases. Here are ten discoveries FFB-funded scientists made this year.

    continue reading "Ten Research Discoveries in 2011"

  • Health Canada Issues a Statement on Use of AvastinŽ to treat Wet AMD

    Dec 8, 2011 - In recent months, there have been media reports about a series of serious infections that occurred in the United States after Avastin® (bevacizumab) was injected into the eye to treat wet age-related macular degeneration. Health Canada has now issued a statement.

    continue reading "Health Canada Issues a Statement on Use of Avastin to Treat Wet AMD"

  • New Wet AMD Drug Approved in the United States

    November 21, 2011 - EYLEA® is similar to other available wet AMD drugs but may permit less frequent injections.

    continue reading "New Wet AMD Drug Approved in the United States"

  • Increasing Dose of Wet AMD Drug Does Not Increase Efficacy

    November 14, 2011 - Injections of the anti-VEGF drug, Lucentis®, can help preserve and, in many cases, improve the vision of people with wet age-related macular degeneration. However, when people don't respond to this drug, some physicians may try an increased dose. A new study shows that this practice is not likely to be effective.

    continue reading "Increasing Dose of Wet AMD Drug Does not Increase Efficacy"

  • First Trial for Choroideremia Begins in England

    November 4, 2011 - A gene therapy for choroideremia has begun human clinical trials.

    Read More

  • Trial of a Gene Therapy for Usher Syndrome to Begin

    A trial of a gene therapy for one type of Usher syndrome is approved to begin at the Casey Eye Institute in Oregon. This therapy is only intended for people with Usher type 1B.

    Read More

  • Aspirin and Age-Related Macular Degeneration (AMD)

    Oct 13, 2011- Recent media coverage has suggested that aspirin may be "bad" for people with AMD. What does the latest research really say, and what do we know about aspirin and AMD?

    Read More

Privacy Policy